Showing results (951-960 of 1,142) with videos related to

Sort By:
Pageof 115
Journal of Hepatology|April 18, 2016
Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimensBenjamin Maasoumy, Johannes Vermehren, Martin-Walter Welker, et al.
Plos One|December 25, 2015
Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World SettingSteffen B Wiegand, Benjamin Heidrich, Simone Susser, et al.
Clinical and Molecular Hepatology|November 21, 2024
Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosisAnja Tiede, Lena Stockhoff, Zhaoli Liu, et al.
Plos One|January 28, 2014
Increased HEV seroprevalence in patients with autoimmune hepatitisSven Pischke, Anett Gisa, Pothakamuri Venkata Suneetha, et al.
Hepatology (Baltimore, Md.)|January 23, 2025
TIGIT expression on natural killer cell subsets is an early indicator of alleviating liver inflammation following bulevirtide treatment in chronic hepatitis DPo-Chun Chen, Katja Deterding, Sophie Anna Engelskircher, et al.
European Journal of Gastroenterology & Hepatology|February 27, 2019
Treatment strategies for patients with decompensated liver cirrhosis due to hepatitis C virus infection eligible for liver transplantation: real-life data from five German transplant centersLisa Sandmann, Petra Dörge, Anika Wranke, et al.
Gut Microbes|April 21, 2025
Distinct clusters of bacterial and fungal microbiota in end-stage liver cirrhosis correlate with antibiotic treatment, intestinal barrier impairment, and systemic inflammationLaura Buttler, David A Velázquez-Ramírez, Anja Tiede, et al.
Journal of Viral Hepatitis|March 15, 2025
Frequency, Severity and Impact of Pegylated Interferon Alpha-Associated Flares in Hepatitis D InfectionSvenja Hardtke, Cihan Yurdaydin, Florin A Caruntu, et al.
Intensive Care Medicine Experimental|November 24, 2021
Effects of therapeutic plasma exchange on the endothelial glycocalyx in septic shockKlaus Stahl, Uta Carola Hillebrand, Yulia Kiyan, et al.
JHEP Reports : Innovation in Hepatology|October 21, 2022
Farnesoid X receptor agonist tropifexor attenuates cholestasis in a randomised trial in patients with primary biliary cholangitisChristoph Schramm, Heiner Wedemeyer, Andrew Mason, et al.
Pageof 115